APA (7th ed.) Citation

Seidu, S., Alabraba, V., Davies, S., Newland-Jones, P., Fernando, K., Bain, S. C., . . . Wilding, J. P. H. (2024). SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review. Diabetes Therapy, 15(5), 1099. https://doi.org/10.1007/s13300-024-01550-5

Chicago Style (17th ed.) Citation

Seidu, Samuel, et al. "SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review." Diabetes Therapy 15, no. 5 (2024): 1099. https://doi.org/10.1007/s13300-024-01550-5.

MLA (9th ed.) Citation

Seidu, Samuel, et al. "SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review." Diabetes Therapy, vol. 15, no. 5, 2024, p. 1099, https://doi.org/10.1007/s13300-024-01550-5.